Navigation Links
Orqis(R) Medical's Cancion(R) System Significantly Increases Cardiac Performance
Date:4/1/2008

MOMENTUM Trial Results Presented at the American College of Cardiology

Annual Meeting

CHICAGO, April 1, 2008 /PRNewswire/ -- Orqis(R) Medical Corporation, a medical products company developing and marketing devices to treat heart failure, announced today that the company's MOMENTUM Trial results were presented during the Late Breaking Clinical Trials session at the annual American College of Cardiology (ACC) meeting in Chicago. The MOMENTUM Trial evaluated the percutaneous Cancion System in patients hospitalized with heart failure.

Barry Greenberg, M.D., Director, Advanced Heart Failure Treatment Program, University of California San Diego Medical Center, and National Principal Investigator for the MOMENTUM Trial, presented, "Efficacy and Safety of Continuous Aortic Flow Augmentation in Patients Hospitalized with Acute Decompensated Heart Failure: Results of the MOMENTUM Trial."

"While the MOMENTUM Trial did not meet its primary composite efficacy endpoint, MOMENTUM is a landmark study demonstrating that the Cancion System, in combination with conventional medical (drug) treatment, statistically significantly improved cardiac performance compared with drug treatment alone," stated Dr. Greenberg. He continued, "There has been very little progress in identifying effective new approaches for treating patients with decompensated heart failure and the Cancion System provides physicians with a needed new treatment option."

Mr. Ken Charhut, President and CEO, Orqis Medical, stated, "MOMENTUM proved that the Cancion System significantly improves cardiac performance." He continued, "Orqis' unique aortic flow therapy bridges the gap between medical management and more invasive procedures without ever touching the heart." The Cancion System is currently available in markets outside the U.S.

About Heart Failure

Over 5 million Americans suffer from heart failure, a condition in which the heart becom
'/>"/>

SOURCE Orqis Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Velos to Develop Key System Interface for Clinical Research
2. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
3. St. Jude Finds Signaling System That Halts the Growth of a Childhood Brain Cancer
4. Inclinix Announces New Patent for Expert System Platform
5. PLC Systems Reports Fourth Quarter 2007 Results
6. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
7. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
8. A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
9. Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System
10. Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System
11. Data Demonstrate that Obagi Medical Products Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...NCETON, N.J., Nov. 30 Co...will present at the Piper Jaffray 21st Annual Heal...at 1:30 p.m. (ET). Investors may access a live we...n order to register and download any necessary sof...ce, with headquarters in Princeton, New Jersey, is...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker.... available in its catalogue: ,, Cardiac Defibr... ,, http://www.reportlinker.com/p0164315/Cardi...e-Report.html ,, Cardiovascular disease (CVD).... Sudden cardiac arrest survivors are prone to arr...
(Date:11/30/2009)...LAUREL, N.J., Nov. 30 Me...f technology-enabled clinical documentation servic...t with Nuance Communications, Inc. (Nuance) under ...ic speech recognition engine and processing softwa...Quist,s front-end speech recognition application f...
Breaking Medicine Technology:Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2NeoGenomics To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 18 2009 14813 1NeoGenomics To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 18 2009 14813 2NQF Helps Ensure Health IT Captures Information to Drive Quality Improvement 6214 1NQF Helps Ensure Health IT Captures Information to Drive Quality Improvement 6214 2NQF Helps Ensure Health IT Captures Information to Drive Quality Improvement 6214 3Gary Wenzel Named President TBWA WorldHealth 6209 1Gary Wenzel Named President TBWA WorldHealth 6209 2Gary Wenzel Named President TBWA WorldHealth 6209 3
...2007 /PRNewswire-FirstCall/ -- Vical,Incorporated ...ted,with the company,s Vaxfectin(TM) adjuvant elic...in juvenile (1 - 2 year old),nonhuman primates con...more than one year after vaccination, and steriliz...disease and no,detectable virus after challenge. I...
..., May 31, 2007 /PRNewswire-FirstCall/ -- Alexza,Ph...resent at the,49th Annual American Headache Societ...l of Staccato(R) prochlorperazine (AZ-001),for the...presentation, "Efficacy and tolerability profile o...ith migraine headache",(Poster S-72), will be avai...
Other Medicine Technology:Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 2Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 3Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 4Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at,the American Headache Society Meeting 2
(Date:11/30/2009)..., , GAINESVILLE, Fla., Nov. 30 /PRNewswire/ -...aCAD marks the availability of the first FDA-clear...etection and analysis by a radiologist of suspicio...ally unveiled at the Radiological Society of North...eloped in partnership with leading experts in brea...
(Date:11/30/2009)...o lab studies report safe transplant results in an...ews) -- Two new studies in animals suggest that st... cord blood could help treat some lung and heart d...stem cells can differentiate into a long list of d... Soon Park of the Samsung Medical Center in Seoul,...
(Date:11/30/2009)..., , WASHINGTON, Nov. 30 - Salo...A Cause" on Monday, December 7(th) to raise funds ...ildhood terminal diseases. All proceeds from each ...hildren,s Research Hospital. ,, Salon Leau has...rs. The salon is owned by LoAnn Lai, widely recogn...
(Date:11/30/2009)..., , PHILADELPHI.../ -- , - Exclusive Updates From Elsevier,...e Reform and ARRA Momentum , Elsevier, a ...n as well,as web-based and electronic health recor...w online resource center for American Recovery and...
(Date:11/30/2009)...UPTON, NY When asked to inhibit their response to...re, on average, able to suppress activity in brain...w study at the U.S. Department of Energy,s Brookha...hed in an upcoming issue of NeuroImage , suggest ... these inhibitory responses could help cocaine abu...
Breaking Medicine News(10 mins):Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 3Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 4Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3
... The frequent spread of certain cancers to lymph ...apy that damages the lymphatic system and can caus...tion that often increases susceptibility to infect...ial growth factor-C (VEGF-C) to replace excised mo...
...RAZER, Pa., Dec. 3 Cephalon, Inc. (Nasdaq:,CEPH) ...stration (FDA) has,accepted and granted priority r...HCl) New Drug Application (NDA) for the first-line...,cases diagnosed every year in the United States. ...
... Springhill Medical Center Latest Healthcare Organ... Information Solution; Activation Completed Ahead ..., LAS VEGAS, Dec. 3 At the 2007 American,Society...et momentum for Sunrise Pharmacy(TM) with seven cl...
...ponsored by The Beryl Institute, Conference to Fea...r in Dallas, March 26-28, 2008, DALLAS, Dec. 3 T...its 2008 conference "The Power of Impressions" to ...erence is,the Ritz-Carlton Leadership Center, whic...
...rogram locks in rates while increasing amount avai...e years at no additional cost, DAYTON, Ohio, Dec....l maximum dollars when you renew your contract and...ximum,Advantage feature that offers their Preferre...
...rowing U.S. Customer Base Surpasses 660 Sites, DE... Bulletin Board: GLOB), an international e-Health,...ounced that its Wyndgate,Technologies(R) division ...orial Hospital (Sheridan) joins a growing,customer...
Other Medicine News:Health News:Lymphatic vessel and lymph node function are restored with growth factor treatment 2Health News:Lymphatic vessel and lymph node function are restored with growth factor treatment 3Health News:TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA 2Health News:TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA 3Health News:TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA 4Health News:TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA 5Health News:Eclipsys Announces Strong Market Momentum for Sunrise Pharmacy 2Health News:Eclipsys Announces Strong Market Momentum for Sunrise Pharmacy 3Health News:Eclipsys Announces Strong Market Momentum for Sunrise Pharmacy 4Health News:Eclipsys Announces Strong Market Momentum for Sunrise Pharmacy 5Health News:'The Power of Impressions' 2008 Conference to Explore Customer Service in Healthcare 2Health News:Superior Dental Care Alliance Launches Maximum Advantage Program 2Health News:Global Med Technologies(R), Inc. Adds Wyoming Hospital to Growing Customer Base 2Health News:Global Med Technologies(R), Inc. Adds Wyoming Hospital to Growing Customer Base 3
...utostat™II Rheumatoid Factor IgM enzyme linked...id Factor IgM (RF IgM). Enzyme-linked immunosorben...of specific IgM Rheumatoid Factor in human serum. ...aid in the diagnosis of Rheumatoid Arthritis when ...
ACUVUE OASYS with HYDRACLEAR™ PLUS
Carriazo-Pendular
...ctor I or somatomedin-C, is a peptide highly depen...ting activity. IGF-I is transported in serum by se...owth disorders, measurements of IGF-I are a useful.... A normal plasma or serum IGF-I concentration is ...
Medicine Products: